Maryland Senate Bill 399 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on February 1 2012 - 25% progression, died in chamber
Action: 2012-02-23 - Unfavorable Report by Finance Withdrawn
Text: Latest bill text (Introduced) [PDF]

Altering the name of the Stem Cell Research Commission to be the Stem Cell and Biotechnologies Commercialization Commission; requiring the Commission to establish procedures and guidelines regarding research supporting a qualified technology; altering the name of the Maryland Stem Cell Research Fund to be the Maryland Stem Cell and Biotechnologies Commercialization Fund; altering the purpose of the Fund so as to support innovative biotechnology research and development that has the potential to create job growth; etc.

Economic Development - Maryland Stem Cell Research Act - Revisions

Sen. Jennie Forehand [D]

Sen. Robert Garagiola [D]

Sen. Catherine Pugh [D]

Date	Chamber	Action
2012-02-23		Unfavorable Report by Finance Withdrawn
2012-02-20		Hearing cancelled
2012-02-01		Hearing 2/23 at 1:00 p.m.
2012-02-01		First Reading Finance

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Search/Legislation?target=/2012rs/billfile/SB0399.htm
Text	http://mlis.state.md.us/2012rs/bills/sb/sb0399f.pdf